What question did this study set out to answer?

To evaluate and differentiate the safety profiles, metabolic pathways, and adverse effect risks across members of the thiazolidinedione class.

January 1, 2002Diabetes/Metabolism Research and ReviewsOpen Access

Differentiating members of the thiazolidinedione class: a focus on safety

View Full Paper

Ask AI

Bookmark

Authors

HLHarold E. LebovitzState University of New York

Discussion

Member takes

Implication

Review reveals distinct safety profiles and cytochrome interactions among thiazolidinediones in type 2 diabetes, highlighting key differences in drug interactions and liver toxicity.

Key Points

To evaluate and differentiate the safety profiles, metabolic pathways, and adverse effect risks across members of the thiazolidinedione class.
Evaluated safety findings from clinical trials and clinical practice for troglitazone, rosiglitazone, and pioglitazone in type 2 diabetes.
Assessed pharmacokinetic pathways involving CYP 3A4 and CYP 2C8 along with PPAR gamma receptor-binding characteristics.
Hepatotoxicity is uniquely associated with troglitazone and does not represent a shared class effect for rosiglitazone or pioglitazone.
Troglitazone and pioglitazone metabolism involves CYP 3A4 and CYP 2C8, posing a greater potential for drug-drug interactions than rosiglitazone, which is primarily metabolized via CYP 2C8.
Shared class-wide effects across all three agents include edema, weight gain, plasma lipid alterations, and hemodilution leading to modest reductions in hemoglobin and hematocrit.

Cite This Study

Harold E. Lebovitz (2002) studied this question.

synapsesocial.com/papers/6a7d768d14bfcdf15b6e5621 https://doi.org/10.1002/dmrr.252

View Full Paper

Ask AI

Bookmark

Implication

Review reveals distinct safety profiles and cytochrome interactions among thiazolidinediones in type 2 diabetes, highlighting key differences in drug interactions and liver toxicity.

Differentiating members of the thiazolidinedione class: a focus on safety

Discussion

Member takes

Implication

Key Points

Cite This Study

Differentiating members of the thiazolidinedione class: a focus on safety

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider